Zobrazeno 1 - 10
of 108
pro vyhledávání: '"Liesbet Van Eycken"'
Autor:
Francesco Giusti, Carmen Martos, Raquel N. Carvalho, Vesna Zadnik, Otto Visser, Manola Bettio, Liesbet Van Eycken
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
This article highlights the recent and ongoing activities of European population-based cancer registries (PBCRs) in data quality and harmonisation in the framework of the collaboration between the European Network of Cancer Registries (ENCR) and the
Externí odkaz:
https://doaj.org/article/fb4107afba4648a687e908fa29bc674a
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-13 (2023)
Abstract Background As both life expectancy and cancer survival improve, the incidence of multiple primary cancer has augmented and is expected to further increase. This study describes for the first time the epidemiology of multiple invasive tumours
Externí odkaz:
https://doaj.org/article/a4247e01e5e3455c827c95d12a1d9cb6
Autor:
Hanna M. Peacock, Cindy De Gendt, Geert Silversmit, Sandra Nuyts, Jan Casselman, Jean-Pascal Machiels, Francesco Giusti, Bart van Gool, Vincent Vander Poorten, Liesbet Van Eycken
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
ObjectiveDuring the first wave of the COVID-19 pandemic in 2020, non-essential health services were suspended in Belgium, and the public was ordered to socially isolate. Underdiagnosis of cancer during this period was reported worldwide. Certain risk
Externí odkaz:
https://doaj.org/article/d29613cc933647f8a70a64f366d04ffe
Autor:
Francesco Giusti, Carmen Martos, Raquel Negrão Carvalho, Liesbet Van Eycken, Otto Visser, Manola Bettio
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Population-based Cancer Registries (PBCRs) are tasked with collecting high-quality data, important for monitoring cancer burden and its trends, planning and evaluating cancer control activities, clinical and epidemiological research and development o
Externí odkaz:
https://doaj.org/article/fbb4ac68e05e4ee6ac664ee77245f2c7
Autor:
Tim Tambuyzer, Dimitri Vanhauwaert, Tom Boterberg, Steven De Vleeschouwer, Hanna M. Peacock, Joanna Bouchat, Geert Silversmit, Freija Verdoodt, Cindy De Gendt, Liesbet Van Eycken
Publikováno v:
Cancers, Vol 16, Iss 1, p 63 (2023)
(1) Background: This study evaluates the impact of the COVID-19 pandemic on the incidence, treatment, and survival of adults diagnosed with malignant brain tumors in Belgium in 2020. (2) Methods: We examined patients aged 20 and older with malignant
Externí odkaz:
https://doaj.org/article/565a822c00334a1bafcbbac05a0d7ab8
Autor:
Lei Huang, Lina Jansen, Rob H.A. Verhoeven, Jelle P. Ruurda, Liesbet Van Eycken, Harlinde De Schutter, Jan Johansson, Mats Lindblad, Tom B. Johannesen, Vesna Zadnik, Tina Žagar, Sjoerd M. Lagarde, Cornelis J.H. van deVelde, Petra Schrotz‐King, Hermann Brenner
Publikováno v:
Cancer Communications, Vol 42, Iss 7, Pp 648-662 (2022)
Abstract Background We previously observed decreasing resection rates of non‐metastatic gastric adenocarcinoma (GaC) in the US and some European countries. If and to what extent these trends affect the trends in overall survival (OS) of patients wi
Externí odkaz:
https://doaj.org/article/1c173c0554064f4d98188a8c5810e3ed
Autor:
Francesco Giusti, Carmen Martos, Annalisa Trama, Manola Bettio, Arantza Sanvisens, Riccardo Audisio, Volker Arndt, Silvia Francisci, Carine Dochez, Josepa Ribes, Laura Pareja Fernández, Anna Gavin, Gemma Gatta, Rafael Marcos-Gragera, Yolande Lievens, Claudia Allemani, Roberta De Angelis, Otto Visser, Liesbet Van Eycken, the ENCR Working Group on Treatment Data Harmonisation
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Population-based cancer registries are responsible for collecting incidence and survival data on all reportable neoplasms within a defined geographical area. During the last decades, the role of cancer registries has evolved beyond monitoring epidemi
Externí odkaz:
https://doaj.org/article/67fec9ad8da14371b59df9cff45cb8c1
Publikováno v:
Cancers, Vol 15, Iss 17, p 4388 (2023)
(1) Background: Haematological malignancies (HMs) represent a heterogeneous group of mostly rare cancers that differ in pathophysiology, incidence, and outcome. (2) Methods: Our study aims to understand the epidemiological situation and trends of 24
Externí odkaz:
https://doaj.org/article/7912630fa5cf4d14a0ebafb30fb09e34
Autor:
Rebecka Arnsrud Godtman, Sebastiaan Remmers, Gunnar Aus, Vera Nelen, Liesbet van Eycken, Arnauld Villers, Xavier Rebillard, Maciej Kwiatkowski, Stephen Wyler, Donella Puliti, Giuseppe Gorini, Alvaro Paez, Marcos Lujan, Teuvo Tammela, Chris Bangma, Anssi Auvinen, Monique J. Roobol
Publikováno v:
European Urology Open Science, Vol 34, Iss , Pp 27-32 (2021)
Background: Identification of intervention-related deaths is important for an accurate assessment of the ratio of benefit to harm in screening trials. Objective: To investigate intervention-related deaths by study arm in the European Randomized Study
Externí odkaz:
https://doaj.org/article/b124c2e1feeb41b3abcea4a4ff52f730
Publikováno v:
Biomedicines, Vol 11, Iss 6, p 1645 (2023)
(1) Background: COVID-19 had a major impact on cancer diagnostics and treatment. Delays in diagnosis of cutaneous melanoma were particularly feared, given the impact on survival and morbidity that comes with advanced stages. Moreover, its incidence i
Externí odkaz:
https://doaj.org/article/748fcefc79f749ee83b6d7c49b0c1344